Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elena Rechkina"'
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Deborah Donnell, Denise Galloway, Stephen Cherne, Kate Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, R. Scott McClelland, Jared M. Baeten, Connie Celum, Nelly Mugo, for the KEN SHE Study Team
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-19 (2021)
Abstract Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate ce
Externí odkaz:
https://doaj.org/article/b9ad1f12a24a46a89d5601c95e84f99c
Autor:
Veronika Tchesnokova, Hovhannes Avagyan, Elena Rechkina, Diana Chan, Mariya Muradova, Helen Ghirmai Haile, Matthew Radey, Scott Weissman, Kim Riddell, Delia Scholes, James R Johnson, Evgeni V Sokurenko
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174132 (2017)
Despite the known clonal distribution of antibiotic resistance in many bacteria, empiric (pre-culture) antibiotic selection still relies heavily on species-level cumulative antibiograms, resulting in overuse of broad-spectrum agents and excessive ant
Externí odkaz:
https://doaj.org/article/72fcd3c851bb4662b40c323904c3ae7d
Autor:
Rebecca J Edgar, Jing Chen, Sashi Kant, Elena Rechkina, Jeffrey S Rush, Lennart Scott Forsberg, Bernhard Jaehrig, Parastoo Azadi, Veronika Tchesnokova, Evgeni V Sokurenko, Haining Zhu, Konstantin V Korotkov, Vijay Pancholi, Natalia Korotkova
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 6 (2016)
Streptococcus pyogenes (Group A Streptococcus or GAS) is a haemolytic human pathogen associated with a wide variety of infections ranging from minor skin and throat infections to life-threatening invasive diseases. The cell wall of GAS consists of pe
Externí odkaz:
https://doaj.org/article/898e4fd163374100885accd17a061732
Autor:
Ruanne V, Barnabas, Elizabeth R, Brown, Maricianah A, Onono, Elizabeth A, Bukusi, Betty, Njoroge, Rachel L, Winer, Denise A, Galloway, Leeya F, Pinder, Deborah, Donnell, Imelda, Wakhungu, Ouma, Congo, Charlene, Biwott, Syovata, Kimanthi, Linda, Oluoch, Kate B, Heller, Hannah, Leingang, Susan, Morrison, Elena, Rechkina, Stephen, Cherne, Torin T, Schaafsma, R Scott, McClelland, Connie, Celum, Jared M, Baeten, Nelly, Mugo
Publikováno v:
NEJM evidence. 1(5)
Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (HPV 16/18/31/33/45/52/
Autor:
Paul K. Drain, Ronit R. Dalmat, Linhui Hao, Meagan J. Bemer, Elvira Budiawan, Jennifer F. Morton, Renee C. Ireton, Tien-Ying Hsiang, Zarna Marfatia, Roshni Prabhu, Claire Woosley, Adanech Gichamo, Elena Rechkina, Daphne Hamilton, Michalina Montaño, Jason L. Cantera, Alexey S. Ball, Inah Golez, Elise Smith, Alexander L. Greninger, M. Juliana McElrath, Matthew Thompson, Benjamin D. Grant, Allison Meisner, Geoffrey S. Gottlieb, Michael J. Gale
Publikováno v:
Journal of Clinical Virology. 161:105420
BackgroundGuidelines for SARS-CoV-2 have relied on limited data on duration of viral infectiousness and correlation with COVID-19 symptoms and diagnostic testing.MethodsWe enrolled ambulatory adults with acute SARS-CoV-2 infection and performed seria
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo
Publikováno v:
NEJM Evidence. 1
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo, for the KEN SHE Study Team
Background: Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.Methods: We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338944cd34fb28160ff019530752cf0a
https://doi.org/10.21203/rs.3.rs-1090565/v1
https://doi.org/10.21203/rs.3.rs-1090565/v1
Autor:
Elizabeth A. Bukusi, Nelly Mugo, Kate B. Heller, Connie Celum, Rachel L. Winer, Denise A. Galloway, Hannah Leingang, Betty Njoroge, Ruanne V. Barnabas, Jared M. Baeten, Deborah Donnell, Elizabeth R. Brown, Maricianah Onono, Stephen L. Cherne, Elena Rechkina, R. Scott McClelland, Susan Morrison
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-19 (2021)
Trials
Trials
Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate cervical ca
Autor:
Kai Deng, Elena Rechkina, Evgeni V. Sokurenko, Veronika Tchesnokova, Mansour Samadpour, Lydia Larson, James D. Ralston, Curtis Fowler, Kirthi K. Kutumbaka, Dagmara I. Kisiela, Hao Geng, Victoria Bowers, Yulia Sledneva, Dina N. Greene, Debarati Choudhury, Iryna Maslova, Hemantha Kulasekara
Publikováno v:
Journal of Clinical Microbiology
bioRxiv
bioRxiv
The recent rise in mutational variants of SARS-CoV-2, especially with changes in the Spike protein, is of significant concern due to the potential ability for these mutations to increase viral infectivity, virulence and/or ability to escape protectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c60ee10e35e5a0b5d5fa735fe64005
https://doi.org/10.1101/2021.02.22.432189
https://doi.org/10.1101/2021.02.22.432189
Autor:
David W Schroeder, Kendra Ferrier, Diana Chan, Veronika Tchesnokova, Thalia Solyanik, Kelly Hansen, James D. Ralston, Lydia Larson, Evgeni V. Sokurenko, Helen Ghirmai Haile, Elena Rechkina, Kim Riddell, Delia Scholes, Spencer Shibuya
Publikováno v:
Clin Infect Dis
We report that fluoroquinolone-resistant Escherichia coli are found in feces of 8.8% of healthy women, with most bacteria belonging to pandemic multidrug-resistant ST131-H30R or ST1193 clonal groups. Moreover, these highly uropathogenic clonal groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef4e26005a24f6481459abbf56bab704
https://europepmc.org/articles/PMC7931843/
https://europepmc.org/articles/PMC7931843/